 SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 GLOBE NEWSWIRE -- Nkarta, Inc. Nasdaq: NKTX, a biopharmaceutical company developing engineered natural killer NK cell therapies to treat cancer, today announced its participation at these upcoming investor conferences: 